Back to Search Start Over

Activation of protein kinase C-θ by insulin and phosphatidylinositol-3,4,5-[(P[O.sub.4]).sub.3] is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. (Signal Transduction)

Authors :
Beeson, Mary
Sajan, Mini P.
Dizon, Michelle
Grebenev, Dmitry
Gomez-Daspet, Joaquin
Miura, Atsushi
Kanoh, Yoshinori
Powe, Jennifer
Bandyopadhyay, Gautam
Standaert, Mary L.
Farese, Robert V.
Source :
Diabetes. August 2003, Vol. 52 Issue 8, p1926, 9 p.
Publication Year :
2003

Abstract

Insulin resistance in type 2 diabetes is partly due to impaired glucose transport in skeletal muscle. Atypical protein kinase C (aPKC) and protein kinase B (PKB), operating downstream of phosphatidylinositol (PI) 3-kinase and its lipid product, PI-3,4,5-[(P[O.sub.4]).sub.3] (PI[P.sub.3]), apparently mediate insulin effects on glucose transport. We examined these signaling factors during hyperinsulinemic-euglycemic clamp studies in nondiabetic subjects, subjects with impaired glucose tolerance (IGT), and type 2 diabetic subjects. In nondiabetic control subjects, insulin provoked twofold increases in muscle aPKC activity. In both IGT and diabetes, aPKC activation was markedly (70-80%) diminished, most likely reflecting impaired activation of insulin receptor substrate (IRS)-1-dependent PI 3-kinase and decreased ability of PI[P.sub.3] to directly activate aPKCs; additionally, muscle PKC-θ levels were diminished by 40%. PKB activation was diminished in patients with IGT but not significantly in diabetic patients. The insulin sensitizer rosiglitazone improved insulin-stimulated IRS-1-dependent PI 3-kinase and aPKC activation, as well as glucose disposal rates. Bicycle exercise, which activates aPKCs and stimulates glucose transport independently of PI 3-kinase, activated aPKCs comparably to insulin in nondiabetic subjects and better than insulin in diabetic patients. Defective aPKC activation contributes to skeletal muscle insulin resistance in IGT and type 2 diabetes, rosiglitazone improves insulin-stimulated aPKC activation, and exercise directly activates aPKCs in diabetic muscle.<br />Skeletal muscle is the major organ for insulin-stimulated glucose disposal (1), and glucose transport is rate limiting for such disposal (2). Impaired activation of glucose transport in muscle contributes importantly [...]

Details

Language :
English
ISSN :
00121797
Volume :
52
Issue :
8
Database :
Gale General OneFile
Journal :
Diabetes
Publication Type :
Periodical
Accession number :
edsgcl.106395058